{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:31:12Z","timestamp":1790487072168,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbrc.2018.07.127","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T19:52:34Z","timestamp":1532634754000},"page":"1861-1867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Direct and rapid identification of T315I-Mutated BCR-ABL expressing leukemic cells using infrared microspectroscopy"],"prefix":"10.1016","volume":"503","author":[{"given":"Christophe","family":"Sandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Feraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Desterke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Khedhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Flamant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.J.","family":"Rasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Bennaceur-Griscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G.","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.07.127_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2018.07.127_bib2","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","article-title":"Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population","volume":"34","author":"Bower","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2018.07.127_bib3","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease","volume":"118","author":"Chomel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.07.127_bib4","doi-asserted-by":"crossref","first-page":"35293","DOI":"10.18632\/oncotarget.9182","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation","volume":"7","author":"Chomel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.07.127_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.18632\/oncotarget.333","article-title":"Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy","volume":"2","author":"Chomel","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.07.127_bib6","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2018.07.127_bib7","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood-2007-03-066936","article-title":"BCR-ABL kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia","volume":"110","author":"O'Hare","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.07.127_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MOH.0000000000000403","article-title":"Resistance in chronic myeloid leukemia: definitions and novel therapeutic agents","volume":"25","author":"Talati","year":"2018","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bbrc.2018.07.127_bib9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1306494","article-title":"PACE Investigators. A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias","volume":"369","author":"Cortes","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.07.127_bib10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bbrc.2004.08.169","article-title":"Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia","volume":"323","author":"Sorel","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.07.127_bib11","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3109\/10428194.2010.520774","article-title":"Extensive analysis of the T315I substitution and detection of additional ABLmutati ons in progenitors and primitive stem cell compartment in a patient with tyrosine kinase inhibitor-resistant chronic myeloid leukemia","volume":"51","author":"Chomel","year":"2010","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbrc.2018.07.127_bib12","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood-2004-05-1941","article-title":"BCR\/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks","volume":"104","author":"Nowicki","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.07.127_bib13","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V97.7.2084","article-title":"BCR-ABL downregulates the DNA repair protein DNA-PKcs","volume":"97","author":"Deutsch","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.07.127_bib14","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/leu.2012.5","article-title":"Prevalence and dynamics of BCR-ABL kinase domain mutations during Imatinib treatment differ in patients with newly diagnosed and recurrent BCR-ABL positive acute lymphoblastic leukemia","volume":"26","author":"Pfeifer","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2018.07.127_bib15","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1073\/pnas.1004408107","article-title":"Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein","volume":"107","author":"J\u00e4r\u00e5s","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2018.07.127_bib16","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/eci.12368","article-title":"DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia","volume":"44","author":"Valent","year":"2014","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2018.07.127_bib17","doi-asserted-by":"crossref","first-page":"19466","DOI":"10.1073\/pnas.0609239103","article-title":"Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants","volume":"103","author":"Skaggs","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2018.07.127_bib18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.sbi.2010.07.007","article-title":"From structure to cellular mechanism with infrared microspectroscopy","volume":"20","author":"Miller","year":"2010","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbrc.2018.07.127_bib19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/sj.leu.2401730","article-title":"Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7","volume":"14","author":"Issaad","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2018.07.127_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.18632\/oncoscience.9","article-title":"Modeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitors","volume":"1","author":"Aggoune","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.bbrc.2018.07.127_bib21","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/ijc.28184","article-title":"The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells","volume":"133","author":"Tiffen","year":"2013","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.bbrc.2018.07.127_bib22","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1038\/sj.onc.1206607","article-title":"Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells","volume":"22","author":"Coppo","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2018.07.127_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data","volume":"31","author":"Irizarry","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2018.07.127_bib24","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bbrc.2018.07.127_bib25","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/bioinformatics\/bti394","article-title":"MADE4: an R package for multivariate analysis of gene expression data","volume":"21","author":"Culhane","year":"2005","journal-title":"Bioinforma. Oxf. Engl."},{"key":"10.1016\/j.bbrc.2018.07.127_bib26","doi-asserted-by":"crossref","first-page":"21982","DOI":"10.18632\/oncotarget.8010","article-title":"Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients","volume":"7","author":"Soverini","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.07.127_bib27","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3324\/haematol.2016.145888","article-title":"Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemia","volume":"101","author":"Baer","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2018.07.127_bib28","doi-asserted-by":"crossref","first-page":"e30743","DOI":"10.1371\/journal.pone.0030743","article-title":"Identification of spectral modifications occurring during reprogramming of somatic cells","volume":"7","author":"Sandt","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.07.127_bib29","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1039\/c0an00509f","article-title":"Tracking infrared signatures of drugs in cancer cells by Fourier transform microspectroscopy","volume":"135","author":"Bellisola","year":"2010","journal-title":"Analyst"},{"key":"10.1016\/j.bbrc.2018.07.127_bib30","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1039\/c2an36393c","article-title":"Rapid recognition of drug-resistance\/sensitivity in leukemic cells by Fourier transform infrared microspectroscopy and unsupervised hierarchical cluster analysis","volume":"138","author":"Bellisola","year":"2013","journal-title":"Analyst"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18316310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18316310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:36:15Z","timestamp":1757763375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18316310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0006291X18316310"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.07.127","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct and rapid identification of T315I-Mutated BCR-ABL expressing leukemic cells using infrared microspectroscopy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.07.127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}